Santiago Karen Murphy
SEC CIK 1732137 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BMY | Bristol Myers Squibb | SVP, Ctrl | 16.7K | — | $455.1K | 6 | 2021-07-01 | 2022-03-14 |
Most active insiders at BMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Elkins David V | EVP, CFO | — | $1.85M |
| 2 | Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | — | $403.5K |
| 3 | Holzer Phil M | SVP, Ctrl | — | $33.8K |
| 4 | Short Bartie Wendy | EVP, Corp. Affairs | — | — |
| 5 | Hoch Lynelle | Pres, Cell Therapy Org | — | — |
| 6 | Poole Ahn Amanda | EVP, CHRO | — | — |
| 7 | Gallman Cari | EVP, GC | — | — |
| 8 | Lenkowsky Adam | EVP, Chief Commercial Off | — | — |
| 9 | Shanahan Karin | EVP, Chief Supply Chain, Ops | — | — |
| 10 | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | — | — |
Santiago Karen Murphy made no open-market trades at BMY in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-16 | 2022-03-14 | BMY | Bristol Myers Squibb | Santiago Karen Murphy | SVP, Ctrl | S - Sale | $69.20 | -6,577 | 16.7K | -28% | -$455.1K | |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Santiago Karen Murphy | SVP, Ctrl | M - OptEx | $0.00 | +11.1K | 17.9K | +163% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Santiago Karen Murphy | SVP, Ctrl | J - Other | $0.00 | +3,933 | 17.2K | +30% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Santiago Karen Murphy | SVP, Ctrl | F - Tax | $68.42 | -6,223 | 16.7K | -27% | -$425.8K |
| D | 2021-07-06 | 2021-07-01 | BMY | Bristol Myers Squibb | Santiago Karen Murphy | SVP, Ctrl | M - OptEx | $0.00 | +1,069 | 15.0K | +8% | $0 |
| D | 2021-07-06 | 2021-07-01 | BMY | Bristol Myers Squibb | Santiago Karen Murphy | SVP, Ctrl | F - Tax | $66.56 | -547 | 14.5K | -4% | -$36.4K |
Purchase Sale Sale after option exercise All abbreviations